Difference between revisions of "Main Page/Featured article of the month/2022"
Shawndouglas (talk | contribs) (Added last month's article of the month; added 2022 link) |
Shawndouglas (talk | contribs) (Added last month's article of the month) |
||
Line 16: | Line 16: | ||
<!-- Below this line begin pasting previous news --> | <!-- Below this line begin pasting previous news --> | ||
<h2 style="font-size:105%; font-weight:bold; text-align:left; color:#000; padding:0.2em 0.4em; width:50%;">Featured article of the month: February 2022:</h2> | <h2 style="font-size:105%; font-weight:bold; text-align:left; color:#000; padding:0.2em 0.4em; width:50%;">Featured article of the month: March 2022:</h2> | ||
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig2 Kruger JofCannRes22 4.png|240px]]</div> | |||
'''"[[Journal:Delta-8-THC: Delta-9-THC’s nicer younger sibling?|Delta-8-THC: Delta-9-THC’s nicer younger sibling?]]"''' | |||
Products containing [[Delta-8-Tetrahydrocannabinol|delta-8-tetrahydrocannabinol]] (Δ<sup>8</sup>-THC) became widely available in most of the United States following the [[2018 Farm Bill]], and by late 2020, those products were core products of [[hemp]] processing companies, especially where [[Tetrahydrocannabinol|delta-9-tetrahydrocannabinol]] (Δ<sup>9</sup>-THC) use remained [[Decriminalization of non-medical cannabis in the United States|illegal]] or required [[ Cannabis (drug)|medical]] authorization. Research on experiences with Δ<sup>8</sup>-THC is scarce, and some state governments have prohibited it because of this lack of knowledge. We conducted an exploratory study addressing a broad range of issues regarding Δ<sup>8</sup>-THC to inform policy discussions and provide directions for future systematic research. ('''[[Journal:Delta-8-THC: Delta-9-THC’s nicer younger sibling?|Full article...]]''')<br /> | |||
|- | |||
|<br /><h2 style="font-size:105%; font-weight:bold; text-align:left; color:#000; padding:0.2em 0.4em; width:50%;">Featured article of the month: February 2022:</h2> | |||
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig1 Feder FrontPlantSci2021 12.jpg|240px]]</div> | <div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig1 Feder FrontPlantSci2021 12.jpg|240px]]</div> | ||
'''"[[Journal:Fertilization following pollination predominantly decreases phytocannabinoids accumulation and alters the accumulation of terpenoids in Cannabis inflorescences|Fertilization following pollination predominantly decreases phytocannabinoids accumulation and alters the accumulation of terpenoids in Cannabis inflorescences]]"''' | '''"[[Journal:Fertilization following pollination predominantly decreases phytocannabinoids accumulation and alters the accumulation of terpenoids in Cannabis inflorescences|Fertilization following pollination predominantly decreases phytocannabinoids accumulation and alters the accumulation of terpenoids in Cannabis inflorescences]]"''' |
Revision as of 17:57, 1 April 2022
If you're looking for other "Article of the Month" archives: 2020 - 2021 - 2022 |
Featured article of the month archive - 2022
Welcome to the CannaQAwiki 2022 archive for the Featured Article of the Month.
Featured article of the month: March 2022:"Delta-8-THC: Delta-9-THC’s nicer younger sibling?" Products containing delta-8-tetrahydrocannabinol (Δ8-THC) became widely available in most of the United States following the 2018 Farm Bill, and by late 2020, those products were core products of hemp processing companies, especially where delta-9-tetrahydrocannabinol (Δ9-THC) use remained illegal or required medical authorization. Research on experiences with Δ8-THC is scarce, and some state governments have prohibited it because of this lack of knowledge. We conducted an exploratory study addressing a broad range of issues regarding Δ8-THC to inform policy discussions and provide directions for future systematic research. (Full article...)
|